These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26055641)

  • 1. The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery.
    Bern M; Sand KM; Nilsen J; Sandlie I; Andersen JT
    J Control Release; 2015 Aug; 211():144-62. PubMed ID: 26055641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin and its application in drug delivery.
    Sleep D
    Expert Opin Drug Deliv; 2015 May; 12(5):793-812. PubMed ID: 25518870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.
    Sand KM; Bern M; Nilsen J; Noordzij HT; Sandlie I; Andersen JT
    Front Immunol; 2014; 5():682. PubMed ID: 25674083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcRn binding properties of an abnormal truncated analbuminemic albumin variant.
    Andersen JT; Daba MB; Sandlie I
    Clin Biochem; 2010 Mar; 43(4-5):367-72. PubMed ID: 20006594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.
    Schmidt MM; Townson SA; Andreucci AJ; King BM; Schirmer EB; Murillo AJ; Dombrowski C; Tisdale AW; Lowden PA; Masci AL; Kovalchin JT; Erbe DV; Wittrup KD; Furfine ES; Barnes TM
    Structure; 2013 Nov; 21(11):1966-78. PubMed ID: 24120761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The New Delivery Strategy of Albumin Carrier Utilizing the Interaction with Albumin Receptors.
    Ishima Y; Maruyama T; Otagiri M; Chuang VTG; Ishida T
    Chem Pharm Bull (Tokyo); 2022; 70(5):330-333. PubMed ID: 35491188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney.
    Zhai XY; Nielsen R; Birn H; Drumm K; Mildenberger S; Freudinger R; Moestrup SK; Verroust PJ; Christensen EI; Gekle M
    Kidney Int; 2000 Oct; 58(4):1523-33. PubMed ID: 11012887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective-- FcRn transports albumin: relevance to immunology and medicine.
    Anderson CL; Chaudhury C; Kim J; Bronson CL; Wani MA; Mohanty S
    Trends Immunol; 2006 Jul; 27(7):343-8. PubMed ID: 16731041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cubilin and megalin co-localize in the neonatal inner ear.
    Tauris J; Christensen EI; Nykjaer A; Jacobsen C; Petersen CM; Ovesen T
    Audiol Neurootol; 2009; 14(4):267-78. PubMed ID: 19202329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin as a versatile platform for drug half-life extension.
    Sleep D; Cameron J; Evans LR
    Biochim Biophys Acta; 2013 Dec; 1830(12):5526-34. PubMed ID: 23639804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human serum albumin fusion proteins and novel applications in drug delivery and therapy.
    Rogers B; Dong D; Li Z; Li Z
    Curr Pharm Des; 2015; 21(14):1899-907. PubMed ID: 25732550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megalin is a receptor for albumin in astrocytes and is required for the synthesis of the neurotrophic factor oleic acid.
    Bento-Abreu A; Velasco A; Polo-Hernández E; Pérez-Reyes PL; Tabernero A; Medina JM
    J Neurochem; 2008 Aug; 106(3):1149-59. PubMed ID: 18466341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of oligomeric structure of human serum albumin during its interaction with polyalbumin receptors in blood serum of patients with viral hepatitis B].
    Gussakovskiĭ EE; Garshinina AV; Bondyreva EIu; Khodzhaev ShKh
    Vopr Med Khim; 1993; 39(2):55-7. PubMed ID: 8511892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.
    Andersen JT; Dee Qian J; Sandlie I
    Eur J Immunol; 2006 Nov; 36(11):3044-51. PubMed ID: 17048273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging and targeted drug delivery using albumin-based nanoparticles.
    Yhee JY; Lee J; Chang H; Lee J; Kwon IC; Kim K
    Curr Pharm Des; 2015; 21(14):1889-98. PubMed ID: 25732551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin: the next-generation delivery technology.
    Howard KA
    Ther Deliv; 2015 Mar; 6(3):265-8. PubMed ID: 25853301
    [No Abstract]   [Full Text] [Related]  

  • 17. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
    Kratz F
    J Control Release; 2008 Dec; 132(3):171-83. PubMed ID: 18582981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
    Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
    Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.
    Seijsing J; Lindborg M; Höidén-Guthenberg I; Bönisch H; Guneriusson E; Frejd FY; Abrahmsén L; Ekblad C; Löfblom J; Uhlén M; Gräslund T
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17110-5. PubMed ID: 25406323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.